Biotron Ltd Total Assets

Latest as of June 2026: AU$3.74 Million AUD ≈ $2.65 Million USD

Biotron Ltd total assets. Based on the latest financial reports, Biotron Ltd (BIT) holds total assets worth AU$3.74 Million AUD (≈ $2.65 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BIT stock market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Biotron Ltd (2000–2026)

Total assets of Biotron Ltd from 2000 to 2026. This chart illustrates how Biotron Ltd's total assets have evolved over time, based on quarterly financial data. See Biotron Ltd share price for real-time trading data and today's change.

Biotron Ltd - Asset Composition Analysis

Biotron Ltd Total Assets Breakdown (June 2026)

Biotron Ltd total assets breakdown as of June 2026. Biotron Ltd's total assets of AU$3.74 Million consist of 42.4% current assets and 57.6% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$0.00	41.6%
Accounts Receivable	AU$18.03K	0.5%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$0.00	0.0%
Intangible Assets	AU$2.13 Million	57.0%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2000–2026)

This chart illustrates how Biotron Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BIT net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Biotron Ltd's current assets represent 42.4% of total assets in 2026, an increase from 26.1% in 2000.
Cash Position: Cash and equivalents constituted 41.6% of total assets in 2026, up from 26.1% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, a decrease from 73.0% in 2000.
Asset Diversification: The largest asset category is intangible assets at 57.0% of total assets.

Biotron Ltd Competitors by Total Assets

Key competitors of Biotron Ltd based on total assets are shown below.

Company	Country	Total Assets
Samsung Biologics Co Ltd KO:207940	Korea	₩12.65 Trillion
Verona Pharma plc F:I9SA	Germany	€572.87 Million
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	China	CN¥20.70 Billion
Immunovant Inc NASDAQ:IMVT	USA	$852.49 Million
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	China	CN¥8.59 Billion
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	China	CN¥37.46 Billion
Amicus Therapeutics Inc NASDAQ:FOLD	USA	$949.87 Million

Biotron Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.94	2.23	9.44
Quick Ratio	1.94	2.23	9.44
Cash Ratio	0.00	0.00	0.00
Working Capital	AU$767.42K	AU$526.89K	AU$3.81 Million

Biotron Ltd - Advanced Valuation Insights

This section examines the relationship between Biotron Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.91
Latest Market Cap to Assets Ratio	1.05
Asset Growth Rate (YoY)	281.4%
Total Assets	AU$3.74 Million
Market Capitalization	$3.94 Million USD

Valuation Analysis

Above Book Valuation: The market values Biotron Ltd's assets above their book value (1.05x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: Biotron Ltd's assets grew by 281.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Biotron Ltd (2000–2026)

The table below shows the annual total assets of Biotron Ltd from 2000 to 2026.

Year	Total Assets	Change
2026-06-30	AU$3.74 Million ≈ $2.65 Million	+281.37%
2025-06-30	AU$980.40K ≈ $693.70K	+98.67%
2024-06-30	AU$493.48K ≈ $349.17K	-88.07%
2023-06-30	AU$4.14 Million ≈ $2.93 Million	+116.95%
2022-06-30	AU$1.91 Million ≈ $1.35 Million	-55.94%
2021-06-30	AU$4.33 Million ≈ $3.06 Million	-44.72%
2020-06-30	AU$7.83 Million ≈ $5.54 Million	+33.62%
2019-06-30	AU$5.86 Million ≈ $4.14 Million	+261.72%
2018-06-30	AU$1.62 Million ≈ $1.15 Million	-21.38%
2017-06-30	AU$2.06 Million ≈ $1.46 Million	-40.87%
2016-06-30	AU$3.48 Million ≈ $2.46 Million	-24.54%
2015-06-30	AU$4.62 Million ≈ $3.27 Million	+147.66%
2014-06-30	AU$1.86 Million ≈ $1.32 Million	-61.70%
2013-06-30	AU$4.87 Million ≈ $3.44 Million	-42.49%
2012-06-30	AU$8.46 Million ≈ $5.99 Million	+219.96%
2011-06-30	AU$2.64 Million ≈ $1.87 Million	+42.35%
2010-06-30	AU$1.86 Million ≈ $1.31 Million	+74.64%
2009-06-30	AU$1.06 Million ≈ $752.73K	-53.08%
2008-06-30	AU$2.27 Million ≈ $1.60 Million	+49.26%
2007-06-30	AU$1.52 Million ≈ $1.07 Million	-68.45%
2006-06-30	AU$4.81 Million ≈ $3.41 Million	+98.22%
2005-06-30	AU$2.43 Million ≈ $1.72 Million	-21.89%
2004-06-30	AU$3.11 Million ≈ $2.20 Million	-47.38%
2003-06-30	AU$5.91 Million ≈ $4.18 Million	-31.55%
2002-06-30	AU$8.63 Million ≈ $6.11 Million	-15.30%
2001-06-30	AU$10.19 Million ≈ $7.21 Million	-75.86%
2000-06-30	AU$42.22 Million ≈ $29.87 Million	--

About Biotron Ltd

AU:BIT Australia Biotechnology

Market Cap

$3.94 Million

AU$5.57 Million AUD

Market Cap Rank

#28965 Global

#1564 in Australia

Share Price

AU$0.00

Change (1 day)

+100.00%

52-Week Range

AU$0.00 - AU$0.00

All Time High

AU$0.30